Induction of glioma cell migration by vitronectin in human serum and cerebrospinal fluid

Journal of Neurosurgery

Volumn 107, Issue 3, 2007, Pages 578-585

  Fukushima, Yuji ^a,b   Tamura, Masakazu ^a   Nakagawa, Hidemitsu ^a   Itoh, Kazuyuki ^a  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^b OSAKA ROSAI HOSPITAL   (Japan)

Author keywords

Cell migration; Cerebrospinal fluid; Glioma; Integrin; Serum; Vitronectin

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; FIBRONECTIN; INTEGRIN ALPHA5 ANTIBODY; PROTEIN ANTIBODY; UNCLASSIFIED DRUG; VITRONECTIN;

ARTICLE; CELL ASSAY; CELL MIGRATION; CEREBROSPINAL FLUID; CHEMOTAXIS; CLINICAL ARTICLE; CONTROLLED STUDY; GLIOMA; GLIOMA CELL; HEATING; HUMAN; HUMAN CELL; MOLECULAR WEIGHT; PARTICLE SIZE; PRIORITY JOURNAL; SERUM; ULTRAFILTRATION;

BRAIN NEOPLASMS; CASE-CONTROL STUDIES; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CHEMOTAXIS; FIBRONECTINS; GLIOMA; HUMANS; VITRONECTIN;

EID: 34548827699     PISSN: 00223085     EISSN: 00223085     Source Type: Journal    
DOI: 10.3171/JNS-07/09/0578     Document Type: Article

References (35)

1. Bello L, Giussani C, Carrabba G, Pluderi M, Costa F, Bikfalvi A: Angiogenesis and invasion in gliomas. Cancer Treat Res 117:263-284, 2004
2. Bolteus AJ, Berens ME, Pilkington GJ: Migration and invasion in brain neoplasms. Curr Neurol Neurosci Rep 1:225-232, 2001
3. Chatterjee S, Matsumura A, Schradermeier J, Gillespie GY: Human malignant glioma therapy using anti-alpha(v)beta3 integrin agents. J Neurooncol 46:135-144, 2000
4. Chicoine MR, Madsen CL, Silvergeld DL: Modification of human glioma locomotion in vitro by cytokines EGF, bFGF, PDGFbb, NGF, and TNFα. Neurosurgery 36:1165-1171, 1995
5. Chicoine MR, Silvergeld DL: Mitogens as motogens. J Neurooncol 35:249-257, 1997
6. Chintala SK, Sawaya R, Gokaslan ZL, Fuller G, Rao JS: Immunohistochemical localization of extracellular matrix proteins in human glioma, both in vivo and in vitro. Cancer Lett 101:107-114, 1996
7. Ding Q, Stewart J Jr, Prince CW, Chang PL, Trikha M, Han X, et al: Promotion of malignant astrocytoma cell migration by osteopontin expressed in the normal brain: differences in integrin signaling during cell adhesion to osteopontin versus vitronectin. Cancer Res 62:5336-5343, 2002
8. Fukushima Y, Ohnishi T, Arita N, Hayakawa T, Sekiguchi K: Integrin alpha3beta1-mediated interaction with laminin-5 stimulates adhesion, migration and invasion of malignant glioma cells. Int J Cancer 76:63-72, 1998
9. Giese A, Bjerkvig R, Berens ME, Westphal M: Cost of migration: invasion of malignant gliomas and implications for treatment. J Clin Oncol 21:1624-1636, 2003
10. Giese A, Westphal M: Glioma invasion in the central nervous system. Neurosurgery 39:235-252, 1996
11. Gladson CL: The extracellular matrix of gliomas: modulation of cell function. J Neuropathol Exp Neurol 58:1029-1040, 1999
12. Gladson CL, Cheresh DA: Glioblastoma expression of vitronectin and the alpha v beta 3 integrin. Adhesion mechanism for transformed glial cells. J Clin Invest 88:1924-1932, 1991
13. Gladson CL, Wilcox JN, Sanders L, Gillespie GY, Cheresh DA: Cerebral microenvironment influences expression of the vitronectin gene in astrocytic tumors. J Cell Sci 108:947-956, 1995
14. Gunther W, Skaftnesmo KO, Arnold H, Terzis AJ: Molecular approaches to brain tumour invasion. Acta Neurochir (Wien) 145:1029-1036, 2003
15. Hamel W, Westphal M: Growth factors in gliomas revisited. Acta Neurochir (Wien) 142:113-138, 2000
16. Hedberg KK, Stauff C, Hoyer-Hansen G, Ronne E, Griffith OH: High-molecular-weight serum protein complexes differentially promote cell migration and the focal adhesion localization of the urokinase receptor in human glioma cells. Exp Cell Res 257:67-81, 2000
17. Lopes MB: Angiogenesis in brain tumors. Microsc Res Tech 60:225-230, 2003
18. Mahesparan R, Read TA, Lund-Johansen M, Skaftnesmo KO, Bjerkvig R, Engebraaten O: Expression of extracellular matrix components in a highly infiltrative in vivo glioma model. Acta Neuropathol (Berl) 105:49-57, 2003
19. Mahesparan R, Tysnes BB, Edvardsen K, Haugeland HK, Cabrera IG, Lund-Johansen M, et al: Role of high molecular weight extracellular matrix proteins in glioma cell migration. Neuropathol Appl Neurobiol 23:102-112, 1997
20. Manning TJ Jr, Parker JC, Sontheimer H: Role of lysophosphatidic acid and rho in glioma cell motility. Cell Motil Cytoskeleton 45:185-199, 2000
21. Oz B, Karayel FA, Gazio NL, Ozlen F, Balci K: The distribution of extracellular matrix proteins and CD44S expression in human astrocytomas. Pathol Oncol Res 6:118-124, 2000
22. Paulus W, Baur I, Schuppan D, Roggendorf W: Characterization of integrin receptors in normal and neoplastic human brain. Am J Pathol 143:154-163, 1993
23. Preissner KT: Structure and biological role of vitronectin. Annu Rev Cell Biol 7:275-310, 1991
24. Rao JS: Molecular mechanisms of glioma invasiveness: the role of proteases. Nat Rev Cancer 3:489-501, 2003
25. Rascher G, Fischmann A, Kroger S, Duffner F, Grote EH, Wolburg H: Extracellular matrix and the blood-brain-barrier in glioblastoma multiforme: spatial segregation of tenascin and agrin. Acta Neuropathol 104:85-91, 2002
26. Rutka JT, Myatt CA, Giblin JR, Davis RL, Rosenblum ML: Distribution of extracellular matrix proteins in primary human brain tumors: an immunohistochemical analysis. Can J Neurol Sci 14:25-30, 1987
27. Sawaya R, Cummins CJ, Smith BH, Kornblith PL: Plasma fibronectin in patients with brain tumors. Neurosurgery 16:161-165, 1985
28. Steiner MR, Urso JR, Klein J, Steiner SM: Multiple astrocyte responses to lysophosphatidic acids. Biochim Biophys Acta 1582:154-160, 2002
29. Suzuki S, Oldberg A, Hayman EG, Pierschbacher MD, Ruoslahti E: Complete amino acid sequence of human vitronectin deduced from cDNA. Similarity of cell attachment sites in vitronectin and fibronectin. Embo J 4:2519-2524, 1985
30. Taga T, Suzuki A, Gonzalez-Gomez I, Gilles FH, Stins M, Shimada H, et al: alpha v-Integrin antagonist EMD 121974 induces apoptosis in brain tumor cells growing on vitronectin and tenascin. Int J Cancer 98:690-697, 2002
31. Thorsen F, Tysnes BB: Brain tumor cell invasion, anatomical and biological considerations. Anticancer Res 17:4121-4126, 1997
32. Tonn JC, Goldbrunner R: Mechanisms of glioma cell invasion. Acta Neurochir Suppl 88:163-167, 2003
33. Tysnes BB, Mahesparan R: Biological mechanisms of glioma invasion and potential therapeutic targets. J Neurooncol 53: 129-147, 2001
34. Yoshioka K, Matsumura F, Akedo H, Itoh K: Small GTP-binding protein Rho stimulates the actomyosin system, leading to invasion of tumor cells. J Biol Chem 273:5146-5154, 1998
35. Zhou Y, Larsen PH, Hao C, Yong VW: CXCR4 is a major chemokine receptor on glioma cells and mediates their survival. J Biol Chem 277:49481-49487, 2002